Fig. 7From: Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLCEffect of pioglitazone on cellular metabolism. Analysis of glycolysis by SeaHorse in lung cancer cells following pioglitazone treatment (range 0.1–10 μM) for 30 min and 2 h. a, b Graphical representation of extracellular acidification rate (ECAR) in H1299 and H460 cell lines: each colored curve indicated concentration of pioglitazone treatment: for H1299 (a): green, untreated control; yellow, 0.1 μM; light blue, 1 μM, and purple, 10 μM. For H460 (b): yellow, untreated control; red,0.1 μM; light blue,1 μM, dark blue, 10 μM. c, d Histograms represented the ECAR quantification time dependent, in H1299 (c) and H460 (d) cell lines. P values < 0.05 were considered as statistically significant (**). e Expression of Glut-1, TKLT1, SLC15A and G6PD evaluated by immunoblotting in H1299 and H460 cell lines. +: pioglitazone 10 μM. α-tubulin was used as the loading controlBack to article page